Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Vaccines For Type 1 Diabetes: Prevention or Reversal?
Desai S, Buchade S, Chitlange S, Sharma H, Bhombe D, Shewale S, Pujari P. Desai S, et al. Among authors: shewale s. Curr Diabetes Rev. 2021;17(1):30-36. doi: 10.2174/1573399816666200330145501. Curr Diabetes Rev. 2021. PMID: 32223735 Review.
Assessment of safety and immunogenicity of two different lots of diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine manufactured using small and large scale manufacturing process.
Sharma HJ, Patil VD, Lalwani SK, Manglani MV, Ravichandran L, Kapre SV, Jadhav SS, Parekh SS, Ashtagi G, Malshe N, Palkar S, Wade M, Arunprasath TK, Kumar D, Shewale SD. Sharma HJ, et al. Among authors: shewale sd. Vaccine. 2012 Jan 11;30(3):510-6. doi: 10.1016/j.vaccine.2011.11.067. Epub 2011 Nov 26. Vaccine. 2012. PMID: 22119927 Clinical Trial.
Th1-Th2 Seesaw: An Essential Aspect in Type 1 Diabetes.
Desai S, Bhonde R, Sharma H, Kamble P, Shimpi J, Pujari P, Parekh S, Shewale S. Desai S, et al. Among authors: shewale s. Curr Diabetes Rev. 2022;18(8):e080322201918. doi: 10.2174/1573399818666220308162514. Curr Diabetes Rev. 2022. PMID: 35260057 No abstract available.
A phase I, open label, clinical study to assess the safety and immunogenicity of indigenously developed liquid (DTwP-HepB-IPV-Hib) hexavalent combination vaccine in healthy toddlers aged 16-24 months.
Sharma H, Lalwani S, Parekh S, Pujari P, Shewale S, Palkar S, Hanumante N, Gokhale S, Ks J, Kumar R, Sharma I, Gairola S. Sharma H, et al. Among authors: shewale s. Hum Vaccin Immunother. 2022 Nov 30;18(6):2146435. doi: 10.1080/21645515.2022.2146435. Epub 2022 Nov 22. Hum Vaccin Immunother. 2022. PMID: 36412272 Free PMC article. Clinical Trial.
69 results